News & Updates

In patients with atopic dermatitis (AD), treatment with the IL-13 cytokine-targeting tralokinumab appears to directly or indirectly improves skin microbial dysbiosis, reports a new trial.

Long-term exposure to air pollutants, including gases and particulate matter, may increase the risk of developing atopic dermatitis (AD), according to a recent study.

In psoriasis patients, treatment with cyclosporin may increase the risk of malignancy without nonmelanoma skin cancer, a recent study has found. Biologic or phototherapy have no such impact.

Itraconazole appears to be effective in the treatment of patients with tinea corporis/cruris (TCC) or ringworm of the body, as shown in a study. However, the treatment duration needs to be longer and, even with successful treatment, many patients experience relapse.

Inflammatory bowel disease appears to be a causal risk factor for both psoriasis and psoriatic arthritis, with Crohn’s disease specifically associated with the development of the two psoriasis outcomes, according to a study.

Hair and nail disorders may occur following contraction of COVID-19 infection, with the development of the dermatological conditions related to a history of severe infection, a study has found.